Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 1/2 4Phase 3 2Phase 4 1Phase 2/3 1Phase 1 1

Status

Recruiting 4Active not recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 6INDUSTRY 1

Study Type

Interventional 7

Sponsor

Cancer Type

Head & Neck 2Breast 2Thoracic 1Other solid neoplasm 1Gastrointestinal 1

Conditions

Turcot syndrome 1Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Nasopharyngeal Carcinoma 1Colorectal Neoplasms 1Breast Neoplasms 1Advanced Malignant Solid Tumors 1Advanced Lung Cancer 1Advanced Breast Cancer 1

Interventions

Specimen Handling 132Magnetic Resonance Spectroscopy 107Biopsy 79pembrolizumab 66Nivolumab 63Carboplatin 62Cisplatin 60Cyclophosphamide 56Paclitaxel 47Radiotherapy 37Gemcitabine 37Bevacizumab 36Dexamethasone 33Pemetrexed 28Rituximab 27Fluorouracil 27Doxorubicin 26olaparib 25Injections 25fludarabine 24durvalumab 24atezolizumab 24Radiation 24Ipilimumab 23Docetaxel 23Oxaliplatin 22Cytarabine 22venetoclax 21Vincristine 21Taxes 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Phase 2 × toripalimab × 30 days × Clear all
NCT07480733 2026-05-29

Phase II Study of JS212/JS213 as Monotherapy and in Combination in Patients With Advanced Malignant Solid Tumors

Shanghai Junshi Bioscience Co., Ltd.

Phase 2 Recruiting
410 enrolled
Other solid neoplasm

Advanced Malignant Solid Tumors

NCT06903858 2026-05-22

PICC-3

Sun Yat-sen University

Phase 2 Recruiting
105 enrolled
Gastrointestinal

Turcot syndrome, Colorectal Neoplasms

NCT07325539 2026-05-22

LIGHT

Sun Yat-sen University

Phase 2 Recruiting
55 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT07602907 2026-05-22

Metronomic Oral Paclitaxel Monotherapy and Combined Immunotherapy for Advanced HER2-Negative Breast Cancer: A Two-Stage Dose Exploration and Expansion Trial

Zhejiang Cancer Hospital

Phase 2 Not yet recruiting
44 enrolled
Breast

Advanced Breast Cancer

NCT06378177 2026-05-19

A Study of LVGN6051 Combination Therapy in Patient With Head and Neck Squamous Cell Carcinoma (HNSCC)

Lyvgen Biopharma Holdings Limited

Phase 2 Active not recruiting
64 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT07309276 2026-05-18

A Phase II Clinical Study Evaluating the Combination Therapy of JS212 in Patients With Advanced Lung Cancer

Shanghai Junshi Bioscience Co., Ltd.

Phase 2 Recruiting
864 enrolled
Thoracic

Advanced Lung Cancer

NCT06618014 2026-05-15

NeoTOP

Sun Yat-sen University

Phase 2 Active not recruiting
51 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡